• Issue

    British Journal of Haematology: Volume 182, Issue 3

    309-456
    August 2018
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Issue Information

Free Access

Issue Information

  • Pages: 309-314
  • First Published: 20 July 2018

Editorial Comment

Combination targeted therapy in chronic lymphocytic leukaemia – can pre-clinical studies translate to the clinic?

Nikolaos Ioannou,  Alan G. Ramsay, 
  • Pages: 315-316
  • First Published: 16 May 2018

Images in Haematology

The diversity of neutrophil inclusion bodies in fulminant sepsis

Karen Boyd,  Sudhir Tauro, 
  • Page: 317
  • First Published: 24 May 2018

Neisseria elongata infection associated with complement inhibition during treatment of paroxysmal nocturnal haemoglobinuria

Rudolf Benz,  Martin Krause,  Sabine Majer,  Christian Taverna,  Kathrin Herzog, 
  • Page: 318
  • First Published: 20 April 2018

Reviews

Pathogenesis, diagnosis and treatment of anaemia in immune-mediated gastrointestinal disorders

Gaetano Bergamaschi,  Antonio Di Sabatino,  Gino R. Corazza, 
  • Pages: 319-329
  • First Published: 06 May 2018

Management of post-transplant lymphoproliferative disorders

Christin B. DeStefano,  Sanjal H. Desai,  Aarthi G. Shenoy,  Joseph P. Catlett, 
  • Pages: 330-343
  • First Published: 09 May 2018

Guidelines

Free Access

Guideline for the treatment of chronic lymphocytic leukaemia: A British Society for Haematology Guideline

Anna H. Schuh,  Nilima Parry-Jones,  Niamh Appleby,  Adrian Bloor,  Claire E. Dearden,  Christopher Fegan,  George Follows,  Christopher P. Fox,  Sunil Iyengar,  Ben Kennedy,  Helen McCarthy,  Helen M. Parry,  Piers Patten,  Andrew R. Pettitt,  Ingo Ringshausen,  Renata Walewska,  Peter Hillmen, 
  • Pages: 344-359
  • First Published: 15 July 2018

Haematological Malignancy

MEK1/2 inhibition by binimetinib is effective as a single agent and potentiates the actions of Venetoclax and ABT-737 under conditions that mimic the chronic lymphocytic leukaemia (CLL) tumour microenvironment

Kyle Crassini,  Yandong Shen,  William S. Stevenson,  Richard Christopherson,  Chris Ward,  Stephen P. Mulligan,  O. Giles Best, 
  • Pages: 360-372
  • First Published: 16 May 2018

Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia

Ana M. Hurtado,  Gines Luengo-Gil,  Tzu H. Chen-Liang,  Fabio Amaral,  Kiran Batta,  Laura Palomo,  Eva Lumbreras,  Bartlomiej Przychodzen,  Eva Caparros,  Marıa L. Amigo,  Maria Dıez-Campelo,  Lurdes Zamora,  Eduardo J. Salido Fierrez,  Jaroslaw P. Maciejewski,  Francisco J. Ortuño,  Vicente Vicente,  Marıa del Canizo,  Francesc Sole,  Francisca Ferrer-Marin,  Daniel H. Wiseman,  Andres Jerez, 
  • Pages: 373-383
  • First Published: 24 May 2018
Open Access

Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review

Anouk van Westrhenen,  Lisanne C. A. Smidt,  Tatjana Seute,  Stefan Nierkens,  Abraham C. J. Stork,  Monique C. Minnema,  Tom J. Snijders, 
  • Pages: 384-403
  • First Published: 29 May 2018

Four-year follow-up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL)

Preetesh Jain,  Jorge Romaguera,  Samer A. Srour,  Hun J. Lee,  Frederick Hagemeister,  Jason Westin,  Luis Fayad,  Felipe Samaniego,  Maria Badillo,  Liang Zhang,  Lorreta Nastoupil,  Rashmi Kanagal-Shamanna,  Nathan Fowler,  Michael L. Wang, 
  • Pages: 404-411
  • First Published: 22 May 2018

Clinical-grade validation of whole genome sequencing reveals robust detection of low-frequency variants and copy number alterations in CLL

Jenny Klintman,  Katerina Barmpouti,  Samantha J. L. Knight,  Pauline Robbe,  Hélène Dreau,  Ruth Clifford,  Kate Ridout,  Adam Burns,  Adele Timbs,  David Bruce,  Pavlos Antoniou,  Alona Sosinsky,  Jennifer Becq,  David Bentley,  Peter Hillmen,  Jenny C. Taylor,  Mark Caulfield,  Anna H. Schuh, 
  • Pages: 412-417
  • First Published: 29 May 2018

Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT

Donal P. McLornan,  Richard Szydlo,  Marie Robin,  Anja van Biezen,  Linda Koster,  Henrik J. P. Blok,  Maria T. Van Lint,  Jürgen Finke,  Antonin Vitek,  Kristina Carlson,  Laimonas Griskevicius,  Ernst Holler,  Maija Itälä-Remes,  Michel Schaap,  Gerard Socié,  Jacques-Olivier Bay,  Yves Beguin,  Benedetto Bruno,  Jan J. Cornelissen,  Tobias Gedde-Dahl,  Per Ljungman,  Marie T. Rubio,  Ibrahim Yakoub-Agha,  Evgeny Klyuchnikov,  Eduardo Olavarria,  Yves Chalandon,  Nicolaus Kröger, 
  • Pages: 418-422
  • First Published: 29 May 2018

Platelets, Haemostasis and Thrombosis

Detection of platelet autoantibodies to identify immune thrombocytopenia: state of the art

Leendert Porcelijn,  Elly Huiskes,  Gonda Oldert,  Martin Schipperus,  Jaap J. Zwaginga,  Masja de Haas, 
  • Pages: 423-426
  • First Published: 29 May 2018

Correspondence

Free Access

Body mass index does not impact on molecular response rate of chronic myeloid leukaemia patients treated frontline with second generation tyrosine kinase inhibitors

Matteo Molica,  Martina Canichella,  Gioia Colafigli,  Roberto Latagliata,  Daniela Diverio,  Giuliana Alimena,  Robin Foà,  Massimo Breccia, 
  • Pages: 427-429
  • First Published: 05 July 2017
Free Access

A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma

Guy Pratt,  Christina Yap,  Ceri Oldreive,  Daniel Slade,  Rebecca Bishop,  Mike Griffiths,  Martin J. S. Dyer,  Chris Fegan,  David Oscier,  Andrew Pettitt,  Estella Matutes,  Stephen Devereux,  David Allsup,  Adrian Bloor,  Peter Hillmen,  George Follows,  Simon Rule,  Paul Moss,  Tatjana Stankovic, 
  • Pages: 429-433
  • First Published: 23 June 2017
Free Access

TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia

Grazia Fazio,  Nice Turazzi,  Valeria Cazzaniga,  Matthias Kreuzaler,  Oscar Maglia,  Chiara F. Magnani,  Ettore Biagi,  Antonius Rolink,  Andrea Biondi,  Giovanni Cazzaniga, 
  • Pages: 434-436
  • First Published: 01 June 2017
Free Access

Cytogenetic findings in WHO-defined polycythaemia vera and their prognostic relevance

Daniela Barraco,  Sonia Cerquozzi,  Curtis A. Hanson,  Rhett P Ketterling,  Animesh D. Pardanani,  Naseema Gangat,  Ayalew Tefferi, 
  • Pages: 437-440
  • First Published: 09 June 2017
Free Access

Management of pregnancy in type 3 von Willebrand disease with alloantibodies

Martin Scott,  Charles R. M. Hay,  Shuayb Elkhalifa,  Clare Tower,  Michael Cocker,  Jecko Thachil, 
  • Pages: 440-442
  • First Published: 12 July 2017
Free Access

A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia

Nicholas J. Short,  Hagop Kantarjian,  Elias Jabbour,  Jorge E. Cortes,  Deborah A. Thomas,  Michael E. Rytting,  Naval Daver,  Yesid Alvarado,  Marina Konopleva,  Partow Kebriaei,  William G. Wierda,  Courtney D. DiNardo,  Carol Bivins,  Deborah McCue,  Mary A. Richie,  Farhad Ravandi, 
  • Pages: 442-444
  • First Published: 14 June 2017
Free Access

Effect of N-acetylcysteine on pain in daily life in patients with sickle cell disease: a randomised clinical trial

Joep W. R. Sins,  Karin Fijnvandraat,  Anita W. Rijneveld,  Martine B. Boom,  Jean-Louis H. Kerkhoffs,  Alfred H. van Meurs,  Marco R. de Groot,  Harriët Heijboer,  Marie-Françoise Dresse,  Phu Quoc Lê,  Philippe Hermans,  Anna Vanderfaeillie,  Eric W. Van Den Neste,  Fleur S. Benghiat,  Rachel Kesse-Adu,  André Delannoy,  André Efira,  Marie-Agnès Azerad,  Corianne A. de Borgie,  Bart J. Biemond, 
  • Pages: 444-448
  • First Published: 23 June 2017
Free Access

Decrease of externalized phosphatidylserine density on red blood cell-derived microparticles in SCA patients treated with hydroxycarbamide

Yohann Garnier,  Séverine Ferdinand,  Philippe Connes,  Marie Garnier,  Maryse Etienne-Julan,  Nathalie Lemonne,  Marc Romana, 
  • Pages: 448-451
  • First Published: 27 June 2017
Free Access

Factors predicting the identification of new organisms in follow-up blood cultures drawn during episodes of neutropenic sepsis

George S. Heriot,  Constantine Tam,  Mary-Jo Waters, 
  • Pages: 451-453
  • First Published: 23 June 2017
Free Access

Diffuse large B cell lymphoma cell of origin by digital expression profiling in the REAL07 Phase 1–2 study

Luciano Cascione,  Andrea Rinaldi,  Annalisa Chiappella,  Ivo Kwee,  Giovannino Ciccone,  Michael Altenbuchinger,  Christian Kohler,  Umberto Vitolo,  Giorgio Inghirami,  Francesco Bertoni, 
  • Pages: 453-456
  • First Published: 24 July 2017